Tayu Huaxia Biotech Medical Group

Tayu Huaxia Biotech Medical Group is a Chinese biotechnology company focused on the development and clinical application of advanced cell therapies. The company specializes in chimeric antigen receptor T-cell (CAR-T) and natural killer (NK) cell technologies, targeting a range of hematological and solid tumors including lymphoma and liver cancer. Beyond therapeutics, Tayu Huaxia provides integrated services such as immune cell storage, genetic testing, and regenerative medicine solutions. Operating from its headquarters in Beijing, the group maintains high-standard GMP manufacturing facilities to support its clinical pipeline and commercial health services. The company aims to provide personalized precision medicine through its proprietary cell engineering platforms.